Logos Capital is a venture capital and private equity firm that specializes in providing growth capital to technology companies. The firm focuses on investments in the technology sector, particularly in software and tech-enabled services businesses that demonstrate strong growth potential and operational excellence.

Logos Capital

Passage Bio

Janux Therapeutics

C4 Therapeutics

Allakos

Alpine Immune Sciences

SomaLogic

Ventyx Biosciences

Verve Therapeutics

Athira Pharma

Centessa Pharmaceuticals

Century Therapeutics

GH Research

Graphite Bio

Immunic Therapeutics

Immunovant

Cullinan Oncology

Dice Therapeutics

Edgewise Therapeutics

Logos Global Management, LP

COM:LOGOSCAPITAL

Logos Capital

People Not Available